Quantitative Models in Life Science Business

From Value Creation to Business Processes

Häftad, Engelska, 2022

Av Jung Kyu Canci, Philipp Mekler, Gang Mu

439 kr

Beställningsvara. Skickas inom 10-15 vardagar

Fri frakt för medlemmar vid köp för minst 249 kr.

This open access book explores the field of life science business from a multidisciplinary perspective. Applying statistical, mathematical, game-theoretic, and data science tools to pharmaceutical and biotechnology business endeavors, the book describes value creation, value maintenance, and value realization in the life sciences as a sequence of processes using the quantitative language of applied mathematics. Written by experts from a variety of fields, the contributions illustrate the shift from a deterministic to a stochastic view of the processes involved, offering a new perspective on life sciences economics. The book covers topics such as valuing and managing intellectual property in life science, licensing in the pharmaceutical business, outsourcing pharmaceutical R&D, and stochastic modelling of a pharmaceutical supply chain. The book will appeal to scholars of economics and the life sciences, as well as to professionals in chemical and pharmaceutical industries.

Produktinformation

Utgivningsdatum2022-11-17
Mått155 x 235 x undefined mm
FormatHäftad
SpråkEngelska
SerieSpringerBriefs in Economics
Antal sidor127
FörlagSpringer International Publishing AG
ISBN9783031118135

Tillhör följande kategorier

Kemi inom Naturvetenskap och teknik
Biokemisk teknik inom Naturvetenskap och teknik
Miljöekonomi inom Ekonomi och ledarskap
Nationalekonomi inom Ekonomi och ledarskap
Medicinsk utrustning och medicinska tekniker inom Medicin

Jung Kyu Canci is a senior lecturer and researcher at the University of Basel and at the Lucerne University of Applied Sciences and Arts in Lucerne, Switzerland. His research is in pure mathematics, number theory, with particular interests in arithmetic of dynamical systems, and in applied mathematics, especially stochastic processes in finance. He is the founder of several companies.Philipp Mekler is trained in both biochemistry and mathematics; he has 40+ years of experience in the Pharma/Life Science sector in R&D, sales/marketing, business analysis and bio-business finance/venture capital in CH/US/IL. Currently, he is working as a strategic advisor at the Roche Pharma International Data and Analytics chapter in Basel, Switzerland.Gang Mu is a visiting research scholar at the University of Zurich, Switzerland and former head of Artificial Intelligence for partnership at Roche, Basel. He holds a Ph.D. degree in mathematics and has comprehensive experience in connecting mathematics, health care and technology, driving impacts and outcomes for patients and healthcare systems. He is the founder of Swiss Network for Mathematics in Industry.

Part I. Value Creation and Managing Intellectual Property in the Life Science Industry.- Chapter 1. Value Creation, Valuation and Business Models in the Pharmaceutical Sector.- Chapter 2. Alternative Licensing Strategies: A Piecewise Deterministic Diﬀerential Game.- Chapter 3. Partnership Models for R&D in the Pharmaceutical Industry.- Part II. Modelling Speciﬁc Business Processes in the Life Science Industry.- Chapter 4. Pharma Tender Processes: Modelling Auction Outcomes.- Chapter 5. Multi-Echelon Inventory Optimization Using Deep Reinforcement Learning.- Part III. Specialized Quantitative Tools in the Life Science Industry.- Chapter 6. Stochastic Diﬀerential Equations in Healthcare.- Chapter 7. Point Processes with Mixed Doubly Stochastic Poisson and Self-Exciting Flavors: An Excursion Into DALY Computations.